Back to Staff Home Page

Joel Hedgpeth, Ph.D.

Complegen, Berlex BioSciences, Codon Corp
Joel Hedgpeth founded Codon Corporation, a biotechnology company that was acquired by Schering, AG in 1990. He served as Vice President of Basic Research at Berlex Biosciences (a US subsidiary of Schering, AG) until 1993. Dr. Hedgpeth was acting Chief Scientific Officer of Epoch Biosciences (NASDQ; EBIO) until 2002. Dr. Hedgpeth received his degree with Herbert W. Boyer (founder of Genentech) at the University of California, San Francisco and after postdoctoral work at the University of Geneva, was a visiting professor at the Pasteur Institute (Paris) and a Research Fellow at the Howard Hughes Institute, UCSF.

www.complegen.com/index.html